ProKidney has acquired inRegen and its subsidiary Twin City Bio.

ProKidney has arranged an initial capital of $75m for financing the acquisition and funding the clinical development of inRegen’s Renal Advanced Cell Therapy (ReACT).

ReACT is an autologous cell therapy conducted to harness the body’s intrinsic capability to repair the damaged kidney tissues and restore them.

Based in the US, InRegen is a biotechnology company engaged in developing advanced cellular therapies (ACT) for treating chronic kidney disease (CKD), while Twin City Bio is a US-based regenerative medicine company focused on producing cell-based therapy products.

“Gencor Pacific has completed an acquisition of InSight Biopharmaceuticals for $2.5m. The acquisition was made through Gencor’s local subsidiary Kinbio.”

ProKidney is a US-based company led by Pablo Legorreta, the founder and CEO of Royalty Pharma.

Quest Products has announced plans to merge with OraHealth Corporation.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The OraCoat® brand of oral care products and Xylimelts® for dry mouth will be added to Quest’s portfolio following the merger.

OraHealth has engaged Cascadia Capital as its advisor for the transaction, while Carney Badley Spellman acted as legal advisor. Quest has engaged Reinhart Boerner Van Deuren as its legal counsel for the transaction.

Based in the US, OraHealth is engaged in the production and manufacturing of natural and non-acidic oral-adhering discs, while Quest Products, also based in the US, is a leading wholesale distributor of consumer packaged goods.

Gencor Pacific has completed an acquisition of InSight Biopharmaceuticals for $2.5m. The acquisition was made through Gencor’s local subsidiary Kinbio.

Based in Hong Kong, Gencor Pacific is a pharmaceutical and food retailer, while InSight Biopharmaceuticals is focused on providing life sciences and analytical solutions.